US4324860A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Lactate dehydrogenase mutants of Streptococcus mutans
Assignee: ADA Forsyth Institute Inc
•
Filing: 1978-10-06
•
Granted: 1982-04-13
•
Expires: 1998-10-06
Abstract
Abstract Mutant strains have been isolated from Streptococcus mutans strain BHT-2(str) which are characterized by a single point mutation in the structural gene for the enzyme, L(+) lactate dehydrogenase, this enzyme being normally responsible for lactic acid production by this bacterium. Streptococcus mutans is believed to be a principal pathogen in dental caries, a disease characterized by the dissolution of the mineral portion of the tooth caused by acid resulting from the interaction of bacteria on the tooth surface with carbohydrates. The mutant strains of the invention will be found useful as prototype nonvirulent effector strains in controlling the incidence and severity of dental caries.
Inventors
- 👤 Jeffrey D. Hillman
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 09:45
CPC Classifications
A; A61; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/64; A61K8/66; C; C12; C12N; C12N1/00; C12N1/20; C12N1/205; A61K35/00; A61K35/66; A61K35/74; A61K35/741; A61K35/744; A61K8/96; A61K8/99; A61Q; A61Q11/00; C12R; C12R2001/00; C12R2001/01; C12R2001/46; Y; Y02; Y02A; Y02A50/00; Y02A50/30; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/822; Y10S435/885
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
91 words
A method of manufacture of a mutant composition useful in the control of the incidence and severity of dental caries, which method comprises: (a) culturing Streptococcus mutans in a suitable nutrient for growing cells of the culture; and (b) isolating and purifying selected mutant strains, to provide a mutant-strain composition consisting essentially of a substantially biologically pure mutant strain characterized by bright red colonies, when grown on glucose tetrazolium medium spheroidal, gram-positive cells occurring in pairs and chains and having a mutation in the structural gene for the enzyme, lactate dehydrogenase.
Claim 2
Independent Claim
91 words
A method of manufacture of a mutant composition useful in the control of the incidence and severity of dental caries, which method comprises: (a) culturing Streptococcus mutans in a suitable nutrient for growing cells of the culture; and (b) isolating and purifying selected mutant strains, to provide a mutant-strain composition consisting essentially of a substantially biologically pure mutant strain characterized by bright red colonies, when grown on glucose tetrazolium medium spheroidal, gram-positive cells occurring in pairs and chains and having a mutation in the structural gene for the enzyme, lactate dehydrogenase.
Claim 3
Dependent Claim
19 words
The method of claim 1 which includes isolating and purifying by streaking the mutant strain on a glucose tetrazolium.
Claim 4
Dependent Claim
12 words
The method of claim 1 wherein the mutant strain is JH 140.
Claim 5
Dependent Claim
12 words
The method of claim 1 wherein the mutant strain is JH 145.
Claim 6
Dependent Claim
12 words
The method of claim 1 wherein the Streptococcus mutans is BHT-2 (str).
Claim 7
Dependent Claim
29 words
The method of claim 1 wherein the mutant is further characterized by colonies of relatively larger colony size than colonies of the parent strain grown on the same medium.
Claim 8
Dependent Claim
56 words
A biologically pure culture of a mutant of Streptococcus mutans strain BHT-2 (str) having a single point mutation in the structural gene for lactate dehydrogenase, being gram positive, having spheroidal cells occurring in pairs and chains and producing on glucose tetrazolium medium bright red colonies of relatively larger size than those produced by the parent strain.
Claim 9
Dependent Claim
56 words
A biologically pure culture of a mutant of Streptococcus mutans strain BHT-2 (str) having a single point mutation in the structural gene for lactate dehydrogenase, being gram positive, having spheroidal cells occurring in pairs and chains and producing on glucose tetrazolium medium bright red colonies of relatively larger size than those produced by the parent strain.
Claim 10
Dependent Claim
16 words
The biologically pure culture of claim 7 wherein the mutant is Streptococcus mutans JH145 (ATCC 31,377).
Claim 11
Dependent Claim
16 words
The biologically pure culture of claim 7 wherein the mutant is Streptococcus mutans JH140 (ATCC 31,341).
Claim 12
Dependent Claim
27 words
The biologically pure culture of claim 7 wherein the mutant is further characterized by a lack of detectable lactic acid when incubated in the presence of glucose.
Claim 13
Dependent Claim
26 words
The biologically pure culture of claim 7 wherein the mutant is further characterized by relatively better adhesion to untreated and saliva-treated hydroxyapatite than said parent strain.
Claim 14
Dependent Claim
42 words
The biologically pure culture of claim 7 wherein the mutant is further characterized by the capacity of the mutant strain to produce more plague on glass slides and tooth-enamel fragments than does the parent strain, when incubated in the presence of sucrose.
Claim 15
Dependent Claim
85 words
The biologically pure culture of claim 7 wherein said mutant strain is further characterized by its ability to metabolize a member from the group consisting of amygdalin, cellobiose, dextran, esculin, fructose, galactan, inulin, lactose, maltose, mannitol, mannose, melibiose, raffinose, ribose, salicin, sorbitol, sucrose, trehalose and pyruvate, as evidenced by a relatively higher pH of cultures of the mutant strain compared to that of the parent strain, when any of said members are incorporated in the culture medium of the parent strain and the mutant strain.
Claim 16
Dependent Claim
13 words
The biologically pure culture of claim 7 in combination with a tetrazolium medium.
Claim 17
Dependent Claim
188 words
A biologically pure culture of a mutant of Streptococcus mutans strain BHT-2 (str) having: (a) bright red colonies, when grown on glucose tetrazolium medium "the colonies of relatively larger colony size than colonies of the parent strain grown on the same medium," spheroidal, gram-positive cells occurring in pairs and chains and having a mutation in the structural gene for the enzyme, lactate dehydrogenase; (b) a lack of detectable lactic acid, when incubated in the presence of glucose; (c) relatively better adhesion to untreated and saliva-treated hydroxyapatite than said parent strain; (d) a capacity to produce more plaque on glass slides and tooth-enamel fragments than does the parent strain, when incubated in the presence of sucrose; and, (e) an ability to metabolize a member from the group consisting of amygdalin, cellobiose, dextran, esculin, fructose, galactose, glucose, inulin, lactose, maltose, mannitol, mannose, melibiose, raffinose, ribose, salicin, sorbitol, sucrose, trehalose and pyruvate, as evidence by a relatively higher pH of cultures of the mutant strain compared to that of the parent strain, when any of said members are incorporated in the culture medium of the parent strain and the mutant strain.
Claim 18
Dependent Claim
188 words
A biologically pure culture of a mutant of Streptococcus mutans strain BHT-2 (str) having: (a) bright red colonies, when grown on glucose tetrazolium medium "the colonies of relatively larger colony size than colonies of the parent strain grown on the same medium," spheroidal, gram-positive cells occurring in pairs and chains and having a mutation in the structural gene for the enzyme, lactate dehydrogenase; (b) a lack of detectable lactic acid, when incubated in the presence of glucose; (c) relatively better adhesion to untreated and saliva-treated hydroxyapatite than said parent strain; (d) a capacity to produce more plaque on glass slides and tooth-enamel fragments than does the parent strain, when incubated in the presence of sucrose; and, (e) an ability to metabolize a member from the group consisting of amygdalin, cellobiose, dextran, esculin, fructose, galactose, glucose, inulin, lactose, maltose, mannitol, mannose, melibiose, raffinose, ribose, salicin, sorbitol, sucrose, trehalose and pyruvate, as evidence by a relatively higher pH of cultures of the mutant strain compared to that of the parent strain, when any of said members are incorporated in the culture medium of the parent strain and the mutant strain.
References Cited (Backward Citations)
US3890200A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-04-12 | 1985-10-12 | 1986-04-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-04-12 | 1989-10-12 | 1990-04-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-04-12 | 1993-10-12 | 1994-04-13 | $7700.00 | Window Closed / Lapsed |